Researchers have made progress in developing a method for non-genotoxic transplantation and in vivo selection through epitope editing, which may enable safer stem cell transplants. This approach could potentially reduce the need for chemotherapy in bone marrow transplants. The technique involves genome editing to modify stem cells, and its applications are being explored for various therapeutic uses, including autoimmune diseases and organ transplantation.